Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

23,712articles mentioning diseases

125,551disease mentions

18,081distinct diseases extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted diseases

Showing 4,201–4,260 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.

Orthorexia nervosa2 Osteogenesis imperfecta (OI)2 Osteonecrosis of the femoral head (ONFH)2 Ovarian vein thrombophlebitis2 PDS2 POD2 PS2 PTS2 Pancreatic neuroendocrine tumors2 Penetrating cardiac injury2 Penile cancer (PeCa)2 Peptic ulcers2 Peripheral eosinophilia2 Peripheral nerve injury2 Peripheral neuropathic pain2 Periprosthetic joint infections2 Pheochromocytomas2 Phrenic nerve block2 Placenta accreta spectrum2 Plasmodium falciparum2 Platinum resistant ovarian cancer2 Platypnoea–orthodeoxia syndrome2 Pleuroparenchymal fibroelastosis2 Polyendocrine metabolic ovarian syndrome (PMOS)2 Porto-sinusoidal vascular disorder2 Post-cardiac arrest syndrome (PCAS)2 Post-dural puncture headache (PDPH)2 Post-streptococcal glomerulonephritis2 Posterior circulation strokes2 Postherpetic neuralgia (PHN)2 Postoperative ileus2 Postoperative sleep disturbance (PSD)2 Primary angiitis of the central nervous system2 Primary breast angiosarcoma2 Primary headache disorders2 Primary lateral sclerosis2 Progressive multifocal leucoencephalopathy2 Progressive multifocal leukoencephalopathy (PML)2 Protracted bacterial bronchitis (PBB)2 Psoriatic arthritis (PsA)2 Pulmonary Artery Hypertension (PAH)2 Pulmonary arteriovenous malformations (PAVMs)2 Pulmonary capillary haemangiomatosis2 Pyogenic liver abscess2 RMDs2 Recurrent glioblastoma2 Recurrent respiratory papillomatosis (RRP)2 Recurrent urinary tract infections2 Renal Transplant2 Restrictive lung disease2 Retinal neurodegeneration2 Road traffic injuries2 Road traffic injuries (RTIs)2 Ruptured intracranial aneurysms (RIAs)2 SARS-CoV-192 SID2 SLE-derived2 SLEDAS2 SLEMethods2 SMA12

View all 18,081 diseases on one page

Articles mentioning diseases

23,712 articles · page 247 of 1976

P.033 BAG3 as a possible therapeutic target and biomarker in systemic sclerosis

jsrd · abstract · 2026-06-05 · 9 matching annotations

96.4%

SSc Skin fibrosis TGF-b1 nintedanib BAG3

… action through BAG3 pathway inhibition (figure 1E).Conclusions SSc skin fibroblasts exhibit constitutive BAG3 overexpression coupl…

P.034 Navigating the single-cell landscape of colonic disease in systemic sclerosis

jsrd · abstract · 2026-06-05 · 9 matching annotations

88.8%

SSc systemic sclerosis immunosuppression

…ysis, we show significant differences in cell abundance between SSc and HC in the colon, that also differ between gastric and colon…

P.040 Closing the seronegative gap in systemic sclerosis with immunoprecipitation–mass spectrometry: a multicentric international study

jsrd · abstract · 2026-06-05 · 9 matching annotations

92.5%

SSc-myositis SSc systemic sclerosis SSc-associated SSc-specific Nippon Medical School Chris Hani Baragwanath Hospital Centre Hospitalier Universitaire d’Angers University of Calgary Centre Hospitalier Lyon Sud+3 more

…ied autoantibodies in more than half of individuals with SSc or SSc-myositis overlap with previously unknown antibody specificity.Abstract P…

P.089 Impact of disease characteristics and patient reported measures on exercise capacity in a prospective SSC-ILD cohort

jsrd · abstract · 2026-06-05 · 9 matching annotations

90.6%

Interstitial lung disease (ILD)SSc-ILD systemic sclerosis (SSc)Visual Analogue Scale Oslo University Hospital Six-Minute Walk Test

…Introduction Interstitial lung disease (ILD) is a frequent and severe manifestation in systemic sclerosis (S…

P.141 Primary heart disease in patients with systemic sclerosis and myocardial iron deposition detected by T2* magnetic resonance

jsrd · abstract · 2026-06-05 · 9 matching annotations

88.9%

fibrosis primary heart disease acute myocarditis

…rdial extracellular volume fraction (ECV) indicative of diffuse fibrosis, T2 mapping indicative of oedema and T2* mapping indicative of …

P.164 Evaluating gastrointestinal involvement in systemic sclerosis using the GIT 2.0 instrument and the impact of immunosuppressive therapy in a Chinese cohort

jsrd · abstract · 2026-06-05 · 9 matching annotations

94.5%

systemic sclerosis (SSc)myositis dcSSc SSc scleroderma renal crisis ILD mycophenolate mofetil tofacitinib tocilizumab rituximab+1 more

…volvement is a common and serious complication in patients with systemic sclerosis (SSc), often leading to poor prognosis and posing ongoing challenges …

P.209 Enrichment criteria for skin progression in future trials: a preliminary analysis of skin progression in limited cutaneous systemic sclerosis and sine scleroderma patients using the EUSTAR cohort

jsrd · abstract · 2026-06-05 · 9 matching annotations

96.9%

sine scleroderma lcSSc SSc Limited cutaneous systemic sclerosis

…he EUSTAR database. Patients were included if they had lcSSc or sine scleroderma, fulfilled the 2013 ACR/EULAR classification criteria, and had …

P.222 Ex vivo calcinosis cutis analysis from patients with systemic sclerosis and dermatomyositis

jsrd · abstract · 2026-06-05 · 9 matching annotations

95.7%

dermatomyositis systemic sclerosis Calcinosis cutis SSc DM calciumphosphate

…n the skin, frequently observed in systemic sclerosis (SSc) and dermatomyositis (DM). CC contributes substantially to morbidity and impaired qu…

P.242 Distinct serum metabolomic profiles differentiate systemic sclerosis with ILD from idiopathic pulmonary fibrosis: an untargeted metabolomic analysis

jsrd · abstract · 2026-06-05 · 9 matching annotations

94.6%

Fibrotic interstitial lung disease (ILD)systemic sclerosis (SSc)dcSSc ILD idiopathic pulmonary fibrosis (IPF)lcSSc ILD SSc Taurine

…Introduction Fibrotic interstitial lung disease (ILD), with no definitive treatment that stabilizes or regresses the …

P.286 Hydroxychloroquine and disease progression in systemic sclerosis: insights from antibody-stratified survival analyses

jsrd · abstract · 2026-06-05 · 9 matching annotations

96.2%

systemic sclerosis (SSc)SSc rheumatic diseases hydroxychloroquine HCQ Hydroxychloroquine (HCQ)Italian Rheumatology centers

… for its immunomodulatory properties and is often prescribed in systemic sclerosis (SSc), despite the lack of confirmation of its efficacy in randomized…

P.291 Regional differences in mental health burden and support in systemic sclerosis: patient and physician perspectives from a multinational real-world survey

jsrd · abstract · 2026-06-05 · 9 matching annotations

92.3%

SSc systemic sclerosis (SSc)EQ-5D EQ-5D-5L

…re.Material and Methods Data were drawn from Adelphi Real World SSc Disease Specific Programme™, a cross-sectional survey of rheuma…

P.339 Upadacitinib in a rare systemic sclerosis–ankylosing spondylitis overlap

jsrd · abstract · 2026-06-05 · 9 matching annotations

97.7%

ankylosing spondylitis systemic sclerosis SSc AS upadacitinib Methotrexate rheumatology

…iagnostic criteria for limited cutaneous systemic sclerosis and ankylosing spondylitis.Results Methotrexate was initiated for uveitis and SSc-related …